Your search matched 57 results
Happy Monday, readers!
Well, that was quick!
President Trump and HHS Secretary Azar gave a slightly delayed, much anticipated speech on the Administration’s Blueprint to lower drug prices.
We took the holiday to rest, play with fireworks (the legal kind, mostly) and now we’re back in action for this week’s dose of health care headlines.
How is it mid-December already?
Summertime…and the livin' is easy.
The first week of January was brimming with activity for life sciences companies.
Hazy, Not So Lazy, Days | Blog
Happy Monday, readers!
Despite dramatic news coming out of Washington in recent days—from the leaked Kavanaugh documents to the “Deep State Deep Throat” anonymous op-ed in the New York Times, the latest Kaiser Health Tracking Poll finds that American voters are still focused on healthcare:
Hello Readers, the federal government may be shut down, but The Week That Was team is firing on all cylinders!
Medicine’s #MeToo Moment | Blog
What a week!
Time's Up for healthcare | Blog
Good morning TWTW readers.
Spent last week watching Shaun White win his third gold medal?
From the Warriors and the Capitals to Bob Baffert, Mike Smith, and Justify doing the near-impossible at the Belmont, June started off with some seriously big wins.
Fancy a Pharma Chinwag? | Blog
We are gobsmacked at the amount of pharma pricing activity following the release of President Trump’s “Blueprint” to lower drug prices.
The Week That Was is back in the New Year, with a new look and new company name: Syneos Health.
Our team kept an eye on a number of stories about opioid “pledges,” top-line data communications and, as always, drug pricing.
A busy week in Washington | Blog
The Week That Was team is making our grocery list and checking Black Friday sales, eager to try a new turkey brine and score some electronics deals.
Our favorite fall TV shows are finally starting back up and we’ve DVRed (yes, it’s a verb people) the Sanders-Klobuchar versus Graham-Cassidy Town Hall debate on CNN.
FDA Lost That Lovin’ Feeling | Blog
The FDA lost its lovin’ feeling this week and we kept busy evaluating Louisiana’s new drug pricing proposal and watching not one, but two, Congressional hearings covering both Right to Try and the national opioid epidemic.
Equifax’s CEO resigned, politics got personal (well, at least email accounts did) and grassroots efforts began to materialize in support of Puerto Rico following the devastating effects of Hurricane Maria.
Can You Feel The Love? | Blog
This week was all about showing the love—from self-admiration to all-out corporate courting.
In the lead up to this Halloween edition of The Week That Was, our headlines are chock full of sour patches, jaw breakers and red hots.
We hope you had a restful weekend, because you’re in for a helping heap of The Week That Was.
Temperatures are finally dropping here, but we’re still seeing highs and lows all over the map.
Betting, Biohacking & BYOD | Blog
CEO’s were making headlines last week for a host of reasons.
Cognitive Dissonance | Blog
Special Issue: At The Races | Blog
Get ready, it is mid-term season!
Fall is officially here, marking week three of the NFL season (we’ve got some Browns fans in the house), the rapid approach of the midterm elections, and the kickoff of the socially acceptable window for ordering pumpkin spice lattes.